Format

Send to

Choose Destination
Nat Rev Clin Oncol. 2014 Apr;11(4):184-6. doi: 10.1038/nrclinonc.2014.42. Epub 2014 Mar 18.

Haematological cancer: idelalisib-targeting PI3Kδ in patients with B-cell malignancies.

Author information

1
Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
2
Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge CB22 3AT, UK.
PMID:
24642682
PMCID:
PMC4536758
DOI:
10.1038/nrclinonc.2014.42
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center